AMBBY vs AMBFF
To understand the difference between Ambu AS - ADR (AMBBY) vs. Ambu AS - Ordinary Shares - Class B (AMBFF) it is enough to know the definitions of ADR and Ordinary Shares - Class B
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMBBY’s FA Score shows that 0 FA rating(s) are green whileAMBFF’s FA Score has 0 green FA rating(s).
- AMBBY’s FA Score: 0 green, 5 red.
- AMBFF’s FA Score: 0 green, 5 red.
Price Growth
AMBBY (@Medical Specialties) experienced а -5.87% price change this week, while AMBFF (@Medical Specialties) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.
Industries' Descriptions
@Medical Specialties (-2.01% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| AMBBY | AMBFF | AMBBY / AMBFF | |
| Capitalization | 3.99B | 3.99B | 100% |
| EBITDA | 396M | 396M | 100% |
| Gain YTD | 20.588 | 27.564 | 75% |
| P/E Ratio | 277.78 | 256.41 | 108% |
| Revenue | 4.61B | 4.61B | 100% |
| Total Cash | 182M | 182M | 100% |
| Total Debt | 915M | 915M | 100% |
AMBBY | AMBFF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 94 | 91 | |
SMR RATING 1..100 | 76 | 76 | |
PRICE GROWTH RATING 1..100 | 48 | 42 | |
P/E GROWTH RATING 1..100 | 91 | 91 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMBFF's Valuation (75) in the null industry is in the same range as AMBBY (96). This means that AMBFF’s stock grew similarly to AMBBY’s over the last 12 months.
AMBFF's Profit vs Risk Rating (91) in the null industry is in the same range as AMBBY (94). This means that AMBFF’s stock grew similarly to AMBBY’s over the last 12 months.
AMBFF's SMR Rating (76) in the null industry is in the same range as AMBBY (76). This means that AMBFF’s stock grew similarly to AMBBY’s over the last 12 months.
AMBFF's Price Growth Rating (42) in the null industry is in the same range as AMBBY (48). This means that AMBFF’s stock grew similarly to AMBBY’s over the last 12 months.
AMBFF's P/E Growth Rating (91) in the null industry is in the same range as AMBBY (91). This means that AMBFF’s stock grew similarly to AMBBY’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
AMBBY and
Correlation & Price change
A.I.dvisor tells us that AMBBY and CLPBY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMBBY and CLPBY's prices will move in lockstep.
| Ticker / NAME | Correlation To AMBBY | 1D Price Change % | ||
|---|---|---|---|---|
| AMBBY | 100% | +0.44% | ||
| CLPBY - AMBBY | 23% Poorly correlated | N/A | ||
| ALGN - AMBBY | 23% Poorly correlated | -0.01% | ||
| GNNDY - AMBBY | 23% Poorly correlated | -0.69% | ||
| AZTA - AMBBY | 23% Poorly correlated | -1.07% | ||
| COO - AMBBY | 23% Poorly correlated | -1.64% | ||
More | ||||
AMBFF and
Correlation & Price change
A.I.dvisor indicates that over the last year, AMBFF has been loosely correlated with ICCM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMBFF jumps, then ICCM could also see price increases.
| Ticker / NAME | Correlation To AMBFF | 1D Price Change % | ||
|---|---|---|---|---|
| AMBFF | 100% | N/A | ||
| ICCM - AMBFF | 47% Loosely correlated | -2.11% | ||
| AHICF - AMBFF | 32% Poorly correlated | N/A | ||
| AMBBY - AMBFF | 3% Poorly correlated | +0.44% | ||
| NNOX - AMBFF | 1% Poorly correlated | +0.17% | ||
| ANSLF - AMBFF | 0% Poorly correlated | N/A | ||
More | ||||